Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1141.7000 -25.90 (-2.22%)
NSE Jan 20, 2026 15:31 PM
Volume: 567.2K
 

1141.70
-2.22%
Deven Choksey
Aurobindo Pharma’s wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a definitive agreement with Lannett Seller Holdco, Inc. to acquire 100% membership interest in Lannett Company LLC.
Aurobindo Pharma Ltd. is trading below all available SMAs
More from Aurobindo Pharma Ltd.
Recommended